NAD+

DIETARY_SUPPLEMENT3 trials

Sponsors

AgelessRx, Nutraceuticals Research Institute

Conditions

AgingCovid19Healthspan ImprovementHealthy AgingLong COVID-19LongevityPost-COVID-19 Syndrome

Phase 2

Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome

CompletedNCT04604704

AgelessRxCovid19, Long COVID-19, Post-COVID-19 Syndrome

Start: 2021-01-28End: 2023-01-23Updated: 2023-01-25

Phase 3

Combination Gerotherapeutic Interventions for Healthspan Improvement

Active, not recruitingNCT07475546

AgelessRxAging, Healthspan Improvement, Longevity

Start: 2025-07-23End: 2026-04-01Target: 30Updated: 2026-03-16

Unknown Phase

Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+

RecruitingNCT06919328

Nutraceuticals Research InstituteHealthy Aging

Start: 2024-10-31End: 2025-06-30Target: 70Updated: 2025-04-09